-
cas:188039-54-5、帕利珠单抗、Palivizumab
-
cas:1453084-36-0、米妥昔单抗、Mirvetuximab
-
cas:1798286-48-2、坎利珠单抗、Camrelizumab
-
cas:905703-97-1、加尼妥单抗、Ganitumab
-
cas:1407495-02-6、伯考赛珠单抗、Bococizumab
-
cas:1858168-59-8、替雷利珠单抗、Tislelizumab
-
cas:2267989-53-5、Datopotamab (anti-TROP2)
-
cas:615258-40-7、迪诺苏单抗、Denosumab
-
cas:815610-63-0、乌司奴单抗、Ustekinumab
-
cas:356547-88-1、贝利木单抗、Belimumab
-
cas:1918185-84-8、替瑞利尤单抗、Tiragolumab
-
cas:1803176-05-7、奥来鲁单抗、Oleclumab
-
cas:331731-18-1、阿达木单抗、Adalimumab (anti-TNF-α)
-
cas:2227102-46-5、Patritumab deruxtecan
-
cas:943609-66-3、维多珠单抗、Vedolizumab
-
cas:1781223-80-0、特立妥珠单抗、Telisotuzumab